Загрузка...
Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
BACKGROUND: Diabetes mellitus type 2 (DM2) is a modifiable risk factor associated with pancreatic carcinogenesis and tumor progression on the basis of epidemiology studies, but the biological mechanisms are not completely understood. The purpose of this study is to demonstrate direct evidence for th...
Сохранить в:
| Опубликовано в: : | Gastroenterol Rep (Oxf) |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7434590/ https://ncbi.nlm.nih.gov/pubmed/32843973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goaa018 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|